EPISODE · Mar 28, 2024 · 31 MIN
Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer
from Keeping Current CME
How do you define high-risk for recurrence in breast cancer? Credit available for this activity expires: [03/27/25] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000352?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
Ready to play
Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer
0:00
31:38
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 31 minutes long.
When was this Keeping Current CME episode published?
This episode was published on March 28, 2024.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!